Vontobel Holding
HAE icon

Vontobel Holding’s Haemonetics HAE Stock Holding History

Vontobel Holding’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,287
Closed -$263K – 1324
2025
Q4 		$263K Sell
3,287
-4,694
-59% -$315K ﹤0.01% 1215
2025
Q3 		$389K Sell
7,981
-3,329
-29% -$206K ﹤0.01% 1026
2025
Q2 		$844K Sell
11,310
-4,529
-29% -$300K ﹤0.01% 738
2025
Q1 		$1.01M Buy
15,839
+2,828
+22% +$192K ﹤0.01% 593
2024
Q4 		$1.02M Buy
13,011
+8,133
+167% +$653K ﹤0.01% 584
2024
Q3 		$392K Buy
4,878
+180
+4% +$14.5K ﹤0.01% 850
2024
Q2 		$389K Buy
+4,698
New +$413K ﹤0.01% 843

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vontobel Holding's HAE Position: Q1 2026 in Review

Vontobel Holding sold out of Haemonetics (HAE) in Q1 2026, closing a stake of 3,287 shares — an estimated $263K sold.

Vontobel Holding first reported a position in HAE in Q2 2024 and held it in 7 quarters. The position peaked at $1.02M in Q4 2024. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Vontobel Holding reported no remaining Haemonetics position as of Q1 2026 after selling out during the quarter.
  • Vontobel Holding sold 3,287 Haemonetics shares in Q1 2026, an estimated $263K.
  • Vontobel Holding first reported a position in Haemonetics in Q2 2024 and held it in 7 quarters.
  • Vontobel Holding's Haemonetics position peaked at $1.02M in Q4 2024.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Vontobel Holding's 13F filing for Q1 2026, filed 8 May 2026.